Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 03, 2023

SELL
$218.65 - $271.46 $524,104 - $650,689
-2,397 Reduced 46.61%
2,746 $738,000
Q2 2023

Aug 07, 2023

SELL
$214.27 - $253.37 $73,708 - $87,159
-344 Reduced 6.27%
5,143 $1.14 Million
Q1 2023

Apr 21, 2023

BUY
$225.79 - $275.2 $228,725 - $278,777
1,013 Added 22.64%
5,487 $1.33 Million
Q4 2022

Jan 31, 2023

SELL
$229.03 - $291.01 $70,312 - $89,340
-307 Reduced 6.42%
4,474 $1.18 Million
Q3 2022

Nov 14, 2022

BUY
$224.46 - $253.15 $10,549 - $11,898
47 Added 0.99%
4,781 $1.08 Million
Q2 2022

Aug 15, 2022

SELL
$230.71 - $256.74 $22,378 - $24,903
-97 Reduced 2.01%
4,734 $1.15 Million
Q1 2022

May 13, 2022

BUY
$219.27 - $242.57 $1.06 Million - $1.17 Million
4,831 New
4,831 $1.17 Million
Q3 2021

Nov 15, 2021

SELL
$212.27 - $248.7 $938,657 - $1.1 Million
-4,422 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$233.58 - $259.14 $1.03 Million - $1.15 Million
4,422 New
4,422 $1.08 Million
Q1 2021

May 17, 2021

SELL
$221.91 - $258.6 $968,637 - $1.13 Million
-4,365 Closed
0 $0
Q4 2020

Feb 11, 2021

SELL
$216.38 - $257.67 $392,729 - $467,671
-1,815 Reduced 29.37%
4,365 $1 Million
Q3 2020

Oct 26, 2020

BUY
$234.65 - $260.95 $397,497 - $442,049
1,694 Added 37.76%
6,180 $1.57 Million
Q2 2020

Aug 14, 2020

BUY
$197.81 - $242.74 $887,375 - $1.09 Million
4,486 New
4,486 $1.06 Million
Q4 2019

Feb 10, 2020

SELL
$189.21 - $243.2 $668,289 - $858,982
-3,532 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$166.7 - $195.41 $588,784 - $690,188
3,532 New
3,532 $651,000
Q4 2018

Feb 13, 2019

SELL
$178.4 - $208.25 $215,150 - $251,149
-1,206 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$185.29 - $208.89 $926 - $1,044
-5 Reduced 0.41%
1,206 $250,000
Q2 2018

Aug 10, 2018

BUY
$166.05 - $186.51 $166 - $186
1 Added 0.08%
1,211 $223,000
Q1 2018

May 15, 2018

BUY
$169.43 - $198.0 $338 - $396
2 Added 0.17%
1,210 $206,000
Q4 2017

Jan 18, 2018

BUY
$168.79 - $188.59 $203,898 - $227,816
1,208
1,208 $210,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Syntal Capital Partners, LLC Portfolio

Follow Syntal Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Syntal Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Syntal Capital Partners, LLC with notifications on news.